• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Stroke represents a massive public health problem. Carotid atherosclerosis plays a
fundamental part in the occurence of ischaemic stroke. European and US guidelines for …

These guidelines will be updated every four years. Vascular centres are encouraged to audit
implementations made as a result of the guidelines. Audit cycles should be repeated and …

Atherosclerotic stenosis of the internal carotid artery is an important cause of stroke. The aim
of this guideline is to analyse the evidence pertaining to medical, surgical and endovascular …

Members of this Guideline Writing Committee (GWC) were selected by the European Society
for Vascular Surgery (ESVS) to represent physicians involved in the management of patients …

Atherosclerosis leading to stenosis of the internal carotid artery is the underlying cause of 8–
15% of ischaemic strokes (symptomatic carotid stenosis). 1–2% of the adult population have …

The management of patients with stroke is often multidisciplinary, involving various
specialties and healthcare professionals. Given the common shared risk factors for stroke …

Background The optimal treatment for patients with asymptomatic carotid artery stenosis is
under debate. Since best medical treatment (BMT) has improved over time, the benefit of …

The management of extracranial cerebrovascular disease, including carotid endarterectomy
(CEA), carotid stenting and medical management is performed by several specialists …

The aim of the present European Stroke Organisation Transient Ischaemic Attack (TIA)
management guideline document is to provide clinically useful evidence-based …